Can a new drug safely control eczema over the long haul?
Disease control
ENROLLING_BY_INVITATION
This trial is investigating whether long-term use of an experimental drug called IMG-007 can safely control moderate-to-severe eczema (atopic dermatitis). The study enrolls people who have already completed a previous IMG-007 trial and will receive the drug as a shot under the sk…
Phase: PHASE2 • Sponsor: Inmagene LLC • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC